Posts Tagged ‘clinical-trials’
Can the controversial FDA approval of Aduhelm backfire and delay the discovery of actual Alzheimer’s treatments? (Yes, it can)
The U.S. Food and Drug Administration (FDA) recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer’s disease. But approval of the drug has provoked mixed reactions from the scientific community. Alzheimer’s disease is characterized by progressive memory loss, spatial disorientation and many other cognitive and behavioural disorders that ultimately lead…
Read MoreCumulus Neuroscience raises $8.3M to develop EEG-based wireless ‘Fitbit for the brain’
Belfast-based Cumulus raises €6.9m for its ‘Fitbit for the brain’ (The Irish Times): … Formerly known as BrainWaveBank, the company has developed a wireless electroencephalogram (EEG) headset and proprietary software platform that use advanced analytics and machine learning to measure cognitive fitness. “This funding will allow us to build on the ground-breaking advances we have made…
Read MoreThe NIH starts spending $1.5 billion in new Brain Research through Advancing Innovative Neuro-technologies (BRAIN) projects
___ NIH Starts to Spend $4.8 Billion in “Extra” Cures Drug Research Money (P&T Community): “The National Institutes of Health (NIH) launched 110 new brain research projects in the fiscal year ending last September (2017) with the first portion of the $1.5 billion over 10 years it will hopefully receive from the 21st Century Cures…
Read MoreSurvey: Parents view Exercise as more effective than Prescription Medications to treat children with ADHD
Consider how research support for ADHD treatments are typically established. The ‘gold-standard’ approach would be a randomized-controlled trial in which children with ADHD are randomly assigned to the treatment or control group. The treatment, whatever it happens to be, would be carefully implemented in a research-based protocol. If possible
Read MoreCan better cognitive testing platforms accelerate pharma’s Alzheimer’s research and development efforts?
. Alzheimer’s cure behind the boom in brain science (Financial Review): “Biogen is one of many members of big pharma seeking the blockbuster drug which will inevitably be worth multiple billions of dollars. Big pharma in the US spends about $US5 billion a year on Alzheimer’s research and development. Exponential growth in the disease over…
Read MoreIs the future of brain sensors and signals open-source or commercial? (Hint: Probably both)
Neuroscientists Join the Open-Source Hardware Movement (IEEE Spectrum): “Graduate students Josh Siegle and Jakob Voigts were planning an ambitious series of experiments at their MIT neuroscience labs in 2011 when they ran into a problem.
Read More